150 related articles for article (PubMed ID: 1660484)
1. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
Serrero G; Zhou J; Mills D; LePak N
J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A.
Serrero G; Lepak NM; Hayashi J; Eisinger DP
Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538
[TBL] [Abstract][Full Text] [Related]
3. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
4. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
5. [The effect of epidermal growth factor and insulin on the specific binding of transforming growth factor beta by NRK-49F and A-459 cell lines].
Sushel'nitskiĭ SI; Stoĭka RS; Kusen' SI
Tsitologiia; 1991; 33(3):80-7. PubMed ID: 1666203
[TBL] [Abstract][Full Text] [Related]
6. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
7. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
8. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
[TBL] [Abstract][Full Text] [Related]
11. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
Ghahary A; Tredget EE; Mi L; Yang L
Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
Santa-Olalla J; Covarrubias L
J Neurosci Res; 1995 Oct; 42(2):172-83. PubMed ID: 8568917
[TBL] [Abstract][Full Text] [Related]
13. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
Braun L; Gruppuso P; Mikumo R; Fausto N
Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
[TBL] [Abstract][Full Text] [Related]
15. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
Piek E; Franzén P; Heldin CH; ten Dijke P
J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
[TBL] [Abstract][Full Text] [Related]
20. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
